Haematex R&D has resulted in a patented method for procoagulant phospholipid (XACT test) which detects microparticles and platelet activation. This low cost method for detecting hypercoagulability has been licensed to a major diagnostic company. We have developed lupus anticoagulant sensitive and LA resistant APTT coagulation reagents in liquid and powder forms and dRVVT in powder form for preparation of freeze dried or frozen reagents. We can supply phospholipids (both native and synthetic), contact activators and equine collagen for platelet function testing. We are keen to engage in practical R&D with any group seeking to develop new methods, reagents or test kits.


Surface Activated Clotting Time test


SACT II is discontinued indefinitely